Genetic testing and tumor surveillance for children with cancer predisposition syndromes

Current Opinion in Pediatrics

Volumn 20, Issue 1, 2008, Pages 1-7

  Rao, Aarati ^a   Rothman, Jennifer ^b   Nichols, Kim E ^b  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Cancer predisposition; Cancer surveillance; Genetic testing

Indexed keywords

BECKWITH WIEDEMANN SYNDROME; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CHILD CARE; CHILDHOOD CANCER; CLINICAL PRACTICE; EARLY DIAGNOSIS; EVIDENCE BASED PRACTICE; FAMILIAL CANCER; GENETIC PROCEDURES; HEMIHYPERTROPHY; HUMAN; MORBIDITY; MORTALITY; NEPHROBLASTOMA; OUTCOME ASSESSMENT; PATIENT CARE; PEDIATRICS; PRIORITY JOURNAL; QUALITY OF LIFE; RETINOBLASTOMA; REVIEW; SURVIVAL; TUMOR GROWTH;

CHILD; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; NEOPLASTIC SYNDROMES, HEREDITARY; POPULATION SURVEILLANCE; PRECANCEROUS CONDITIONS; SYNDROME;

EID: 38149091915     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e3282f4249a     Document Type: Review

References (40)

1. Strahm B, Malkin D. Hereditary cancer predisposition in children: genetic basis and clinical implications. Int J Cancer 2006; 119:2001-2006. This minireview discusses the genetic basis and clinical issues related to the treatment of children with cancer-predisposing conditions, including retinoblastoma, Li-Fraumeni syndrome, multiple endocrine neoplasia and Fanconi anemia.
2. American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003; 21:2397-2406.
3. Lohmann DR, Gallie BL. Retinoblastoma: revisiting the model prototype of inherited cancer. Am J Med Genet C Semin Med Genet 2004; 129:23-28.
4. Gallie BL. Predictive testing for retinoblastoma comes of age [comment]. Am J Hum Genet 1997; 61:279-281.
5. Popovic MB, Diezi M, Kuchler H, et al. Trilateral retinoblastoma with suprasellar tumor and associated pineal cyst. J Pediatr Hematol Oncol 2007; 29:53-56.
6. Kivela T. Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J Clin Oncol 1999; 17:1829-1837.
7. Fletcher O, Easton D, Anderson K, et al. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Instit 2004; 96:357-363.
8. Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323:643-646.
9. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81:323-330.
10. Dryja TP, Mukai S, Petersen R, et al. Parental origin of mutations of the retinoblastoma gene. Nature 1989; 339:556-558.
11. Richter S, Vandezande K, Chen N, et al. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet 2003; 72:253-269.
12. Nichols KE, Houseknecht MD, Godmilow L, et al. Sensitive multistep clinical molecular screening of 180 unrelated individuals with retinoblastoma detects 36 novel mutations in the RB1 gene. Hum Mutat 2005; 25:566-574.
13. Imhof SM, Moll AC, Schouten-van Meeteren AYN. Stage of presentation and visual outcome of patients screened for familial retinoblastoma: nationwide registration in the Netherlands. Br J Ophthalmol 2006; 90:875-878.
14. Moll AC, Imhof SM, Meeteren AY, Boers M. At what age could screening for familial retinoblastoma be stopped? A register based study 1945-98. Br J Ophthalmol 2000; 84:1170-1172.
15. Abramson DH, Beaverson K, Sangani P, et al. Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival. Pediatrics 2003; 112 (6 Pt 1):1248-1255.
16. Lapunzina P. Risk of tumorigenesis in overgrowth syndromes: a comprehensive review. Am J Med Genet C Semin Med Genet 2005; 137:53-71.
17. Tan TY, Amor DJ. Tumour surveillance in Beckwith-Wiedemann syndrome and hemihyperplasia: a critical review of the evidence and suggested guidelines for local practice. J Paediatr Child Health 2006; 42:486-490. This article presents guidelines for tumor surveillance in patients with BWS.
18. Weideman H-R. Tumours and hemihypertrophy associated with Wiedemann-Beckwith syndrome. Eur J Pediatr 1983; 141:129.
19. DeBaun MR, Tucker MA. Risk of cancer during the first four years of life in children from the Beckwith-Wiedemann Syndrome Registry. J Pediatr 1998; 132 (3 Pt 1):398-400.
20. Goldman M, Smith A, Shuman C, et al. Renal abnormalities in Beckwith-Wiedemann syndrome are associated with 11p15.5 uniparental disomy. J Am Soc Nephrol 2002; 13:2077-2084.
21. Engel JR, Smallwood A, Harper A, et al. Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome. J Med Genet 2000; 37:921-926.
22. Rump P, Zeegers MP, van Essen AJ. Tumor risk in Beckwith-Wiedemann syndrome: a reviewand meta-analysis. Am J Med Genet A 2005; 136:95-104.
23. DeBaun MR, Niemitz EL, McNeil DE, et al. Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Hum Genet 2002; 70:604-611.
24. Bliek J, Maas SM, Ruijter JM, et al. Increased tumour risk for BWS patients correlates with aberrant H19 and not KCNQ1OT1 methylation: occurrence of KCNQ1OT1 hypomethylation in familial cases of BWS. Hum Mol Genet 2001; 10:467-476.
25. Craft AW. Growth rate of Wilms' tumour. Lancet 1999; 354:1127.
26. McNeil DE, Brown M, Ching A, DeBaun MR. Screening for Wilms tumor and hepatoblastoma in children with Beckwith-Wiedemann syndromes: a costeffective model. Med Pediatr Oncol 2001; 37:349-356.
27. Choyke PL, Siegel MJ, Craft AW, et al. Screening for Wilms tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy. Med Pediatr Oncol 1999; 32:196-200.
28. Clericuzio CL, Chen E, McNeil DE, et al. Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia. J Pediatr 2003; 143:270-272.
29. Everman DB, Shuman C, Dzolganovski B, et al. Serum alpha-fetoprotein levels in Beckwith-Wiedemann syndrome. J Pediatr 2000; 137:123-127.
30. Miller RW, Young JL Jr, Novakovic B. Childhood cancer. Cancer 1995; 75(1 Suppl):395-405.
31. Breslow N, Olshan A, Beckwith JB, Green DM. Epidemiology of Wilms tumor. Med Pediatr Oncol 1993; 21:172-181.
32. Scott RH, Stiller CA, Walker L, Rahman N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet 2006; 43:705-715. This is a comprehensive review of the syndromic and nonsyndromic genetic conditions associated with increased risk for development of WT.
33. Ruteshouser EC, Huff V. Familial Wilms tumor. Am J Med Genet 2004; 129:29-34.
34. Rahman N, Arbour L, Tonin P, et al. Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21. Nat Genet 1996; 13:461-463.
35. McDonald JM, Douglass EC, Fisher R, et al. Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors. Cancer Res 1998; 58:1387-1390.
36. Pelletier J, Bruening W, Li FP, et al. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour. Nature 1991; 353:431-434.
37. Huff V. Wilms tumor genetics. Am J Med Genet 1998; 79:260-267.
38. Royer-Pokora B, Beier M, Henzler M, et al. Twenty-four new cases of WT1 germline mutations and review of the literature: genotype/phenotype correlations for Wilms tumor development. Am J Med Genet A 2004; 127:249-257.
39. Little SE, Hanks SP, King-Underwood L, et al. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study. J Clin Oncol 2004; 22:4140-4146.
40. Scott RH, Walker L, Olsen OE, et al. Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice. Arch Dis Child 2006; 91:995-999. This manuscript provides recommendations for Wilms' tumor surveillance based on a review of available evidence from the literature.